CPSI Names William J. Hayes, M.D., Medical Director
October 13, 2016
Appointment is a Signal of CPSI’s Commitment to Physician Adoption
of Healthcare Information Technology in Small and Rural Communities
MOBILE, Ala.--(BUSINESS WIRE)--
CPSI (NASDAQ: CPSI), a leading provider of healthcare information
solutions, today announced that William J. Hayes, M.D. has joined the
Company as a Medical Director with its Physician Adoption team.
As part of the Physician Adoption team, Dr. Hayes will focus on
improving the user experience rural providers have with all CPSI
solutions. He will work with fellow CPSI Medical Director, Ron Louks, MD
and MBA, collaborating with physicians across the CPSI family of
companies. Leveraging existing client channels such as the CPSI
Physician Council, Early Adopter and Pilot programs, the Physician
Adoption team is focused on ensuring clinical solutions are aligned to
meet their needs and preferences when it comes to workflows, training,
and education specific to physicians.
“Bill Hayes brings additional experience to our organization and to our
focused efforts to align our products and services with the unique needs
of rural physicians,” said Boyd Douglas, president and chief executive
officer of CPSI. “Physician Adoption is critical to the success of
community healthcare. Representing the interests of our client
physicians and consulting directly with them will be an important role
for Dr. Hayes.”
Anticipating his new role, Dr. Hayes said, “I am looking forward to
working with CPSI and Dr. Louks as an advocate for physicians who are
dedicated to improving population health in their communities. I am
proud to be representing the voices of thousands of physicians. I think
we can make real progress by addressing the unique challenges in rural
America and making it easier for physicians to do what they do best,
which is keeping their patients healthy.”
In addition to his M.D. from Rutgers University’s Robert Wood Johnson
Medical School, Dr. Hayes completed his MBA from the Mitchell College of
Business at the University of South Alabama. He has also been a Fellow
of the American College of Cardiology. Dr. Hayes’ most recent experience
has been as a Physician Executive with Cerner Corporation in Kansas
City, Medical Director of Cardiovascular Diagnostic Services for
Internal Medicine Center in Mobile, as well as an Executive Physician
Consultant for Eclipsys Corporation of Atlanta. He has held several
other executive positions and was a partner/owner of Cardiology
Associates PC of Mobile, where he practiced cardiology and critical care
medicine at five hospitals. He was previously a Chief Cardiology Fellow
at Texas Heart Institute.
About CPSI
CPSI is a leading provider of healthcare IT solutions and services for
rural and community hospitals and post-acute care facilities. Founded in
1979, CPSI is the parent of five companies – Evident, LLC, TruBridge,
LLC, Healthland Inc., American HealthTech, Inc., and Rycan Technologies,
Inc. Our combined company is focused on helping improve the health of
the communities we serve, connecting communities for a better patient
care experience, and improving the financial operations of our
customers. Evident provides comprehensive EHR solutions and services for
rural and community hospitals. TruBridge focuses exclusively on
providing business management, consulting and managed IT services to
rural and community healthcare organizations, regardless of their IT
vendor. Healthland provides integrated technology solutions and services
to small rural and critical access hospitals. American HealthTech is one
of the nation's largest providers of financial and clinical technology
solutions and services for post-acute care facilities. Rycan provides
revenue cycle management and workflow and automation software to
hospitals, healthcare systems, and skilled nursing organizations. For
more information, visit www.cpsi.com,
www.evident.com,
www.trubridge.com,
www.healthland.com,
www.healthtech.net
or www.rycan.com.
Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements can be
identified generally by the use of forward-looking terminology and words
such as "expects," "anticipates," "estimates," "believes," "predicts,"
"intends," "plans," "potential," "may," "continue," "should," "will" and
words of comparable meaning. Without limiting the generality of the
preceding statement, all statements in this press release relating to
estimated and projected earnings, margins, costs, expenditures, cash
flows, growth rates and future financial results are forward-looking
statements. We caution investors that any such forward-looking
statements are only predictions and are not guarantees of future
performance. Certain risks, uncertainties and other factors may cause
actual results to differ materially from those projected in the
forward-looking statements. Such factors may include: overall business
and economic conditions affecting the healthcare industry, including the
potential effects of the federal healthcare reform legislation enacted
in 2010, and implementing regulations, on the businesses of our hospital
customers; government regulation of our products and services and the
healthcare and health insurance industries, including changes in
healthcare policy affecting Medicare and Medicaid reimbursement
rates and qualifying technological standards; changes in customer
purchasing priorities, capital expenditures and demand for information
technology systems; saturation of our target market and hospital
consolidations; general economic conditions, including changes in the
financial and credit markets that may affect the availability and cost
of credit to us or our customers; our substantial indebtedness, and our
ability to incur additional indebtedness in the future; our inability to
generate sufficient cash in order to meet our debt service obligations;
restrictions on our current and future operations because of the terms
of our senior secured credit facilities; market risks related to
interest rate changes; our ability to successfully integrate the
businesses of Healthland, American HealthTech and Rycan with our
business and the inherent risks associated with any potential future
acquisitions; competition with companies that have greater financial,
technical and marketing resources than we have; failure to develop new
or enhance current technology and products in response to market
demands; failure of our products to function properly resulting in
claims for losses; breaches of security and viruses in our systems
resulting in customer claims against us and harm to our reputation;
failure to maintain customer satisfaction through new product releases
or enhancements free of undetected errors or problems; interruptions in
our power supply and/or telecommunications capabilities, including those
caused by natural disaster; our ability to attract and retain qualified
customer service and support personnel; failure to properly manage
growth in new markets we may enter; misappropriation of our intellectual
property rights and potential intellectual property claims and
litigation against us; changes in accounting principles generally
accepted in the United States; fluctuations in
quarterly financial performance due to, among other factors, timing of
customer installations; and other risk factors described from time to
time in our public releases and reports filed with the Securities
and Exchange Commission, including, but not limited to, our most recent
Annual Report on Form 10-K. We also caution investors that the
forward-looking information described herein represents our outlook only
as of this date, and we undertake no obligation to update or revise any
forward-looking statements to reflect events or developments after the
date of this press release.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161013005228/en/
CPSI
Tracey Schroeder, 612-787-3125
Chief Marketing Officer
tracey.schroeder@cpsi.com
Source: CPSI